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In Guinea, for the majority of the 8 millions inhabitants,
essential medicines remain unavailable and unaffordable.
With the high cost of the imported drugs, it is less than
10% of the urban populations that benefited of these.
Consequently, malaria and HIV/AIDS continue to claim
innumerable lives over the country. The high cost and
scarcity of many essential drugs as well as antiretroviral
drugs has led the majority of people living with HIV/AIDS
to use traditional herbal treatment for a variety of HIV-
related conditions including opportunistic infections.
Such widespread use of traditional medicine by people
living with HIV/AIDS along with the role of traditional
healers in contributing to AIDS prevention and support
may be of interest in view to identify, evaluate and
develop safe and effective local treatments for HIV-
related-illnesses. Aiming that, an ethnopharmacological
survey (2002–2005) over the country led to the recruit-
ment of 418 traditional healers (36 to 87 years old), all
assuming to be able to treat at least one Sexual Transmit-
ted Diseases (STD) such as gonorrhoeae, syphilis, AIDS...
From these healers, 370 have already heard about HIV/
AIDS and only 120 have declared to be able to treat spe-
cifically "HIV/AIDS". After three educational sessions
focused on the prevalence, the contamination, the preven-
tion and the treatment of both STD and HIV/AIDS, only
9/120 traditional healers were affirmative in being able to
cure the disease. An ethnobotanical study has allowed a
collection of 190 traditional recipes containing 218 plants
used in the traditional treatment of STD. Of the 190 bio-
logically tested extracts, 11 have shown a moderate in
vitro antimicrobial effect against Staphylococcus aureus,
Mycobacterium fortuitum, Candida albicans, and Herpes
simplex virus. Of the 184 extracts tested for their anti-HIV
effect, 12 have shown a moderate activity on both strain
of the virus (VIH1 and 2). Bioassay guided fractionation
on the most active extract resulted in the isolation of some
anti-HIV compounds which are under structural investi-
gations. A therapeutic evaluation of two traditional reme-
dies were done under the auspice of the traditional healers
and within their social environment. Significant adverse
effects have been observed with one remedy. A slight
increase of the CD4/CD8 burden was recorded.
These preliminaries results provide evidence on the pres-
ence of biologically active constituents. However, due to
the adverse effects, an attention must be paid in their uses.
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